BCP-ALL develops by transformation of normal B cell progenitors in the bone marrow, which do not express BLyS receptors [8]; therefore, the recent discovery of BR3 on BCP-ALLs was somewhat unexpected [12], [13]. This evidence concerns the gene TNFRSF13C and acute lymphoblastic leukemia.